Arcosa (ACA) President & CEO gains Arcosa Phantom Stock Units in insider filing
Rhea-AI Filing Summary
Arcosa, Inc. reported a routine equity-related transaction for its President & CEO and Director. On 12/31/2025, the reporting person acquired 2 Arcosa Phantom Stock Units under the Arcosa, Inc. Deferred Plan for Director Fees. Each phantom stock unit is the economic equivalent of one share of Arcosa common stock and is designed to mirror the value of the stock without issuing actual shares. Following this transaction, the reporting person beneficially owned 4,881 phantom stock units on a direct basis. These units are settled in cash when the reporting person’s service with Arcosa ends, rather than through delivery of common shares.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Arcosa (ACA) report in this Form 4?
Arcosa reported that its President & CEO, who is also a Director, acquired 2 Arcosa Phantom Stock Units on 12/31/2025 under the company’s Deferred Plan for Director Fees.
What are Arcosa Phantom Stock Units mentioned in the ACA filing?
The filing states that each Arcosa Phantom Stock Unit is the economic equivalent of one share of common stock. These units track the value of Arcosa’s common stock but do not represent actual shares.
How and when are Arcosa Phantom Stock Units settled for the ACA insider?
According to the disclosure, the phantom stock units settle in cash upon the reporting person’s termination of services with Arcosa, rather than being settled in shares.
How many Arcosa Phantom Stock Units does the reporting person hold after this transaction?
After acquiring 2 additional units, the reporting person beneficially owned 4,881 Arcosa Phantom Stock Units, held with direct ownership as shown in the filing.
What role does the reporting person hold at Arcosa (ACA)?
The filing identifies the reporting person as both a Director and an Officer, with the title President & CEO of Arcosa, Inc.